Cargando…
Disease Entities in Mucormycosis
Mucormycosis is an emerging life-threatening fungal infection caused by Mucorales. This infection occurs mainly in immunocompromised patients, especially with hematological malignancy, transplantation, or diabetes mellitus. Rhino-orbito-cerebral and pulmonary mucormycosis are the predominant forms....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462957/ https://www.ncbi.nlm.nih.gov/pubmed/30875744 http://dx.doi.org/10.3390/jof5010023 |
_version_ | 1783410668472369152 |
---|---|
author | Serris, Alexandra Danion, François Lanternier, Fanny |
author_facet | Serris, Alexandra Danion, François Lanternier, Fanny |
author_sort | Serris, Alexandra |
collection | PubMed |
description | Mucormycosis is an emerging life-threatening fungal infection caused by Mucorales. This infection occurs mainly in immunocompromised patients, especially with hematological malignancy, transplantation, or diabetes mellitus. Rhino-orbito-cerebral and pulmonary mucormycosis are the predominant forms. Interestingly, location is associated with the underlying disease as pulmonary mucormycosis is more frequent in hematological malignancy patients whereas rhino-orbito-cerebral mucormycosis is associated with diabetes. Cutaneous mucormycosis results from direct inoculation, mainly after trauma or surgery. Gastro-intestinal mucormycosis occurs after ingestion of contaminated food or with contaminated device and involves the stomach or colon. Disseminated disease is the most severe form and is associated with profound immunosuppression. Uncommon presentations with endocarditis, osteoarticluar or isolated cerebral infections are also described. Finally, health-care associated mucormycosis is a matter of concern in premature newborns and burn units. Clinical symptoms and CT scan findings are not specific, only the early reversed halo sign is associated with pulmonary mucormycosis. Circulating Mucorales DNA detection is a recent promising diagnostic tool that may lead to improving the diagnosis and prompting therapeutic initiation that should include antifungal treatment, correction of the underlying disease and surgery when feasible. |
format | Online Article Text |
id | pubmed-6462957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64629572019-04-17 Disease Entities in Mucormycosis Serris, Alexandra Danion, François Lanternier, Fanny J Fungi (Basel) Review Mucormycosis is an emerging life-threatening fungal infection caused by Mucorales. This infection occurs mainly in immunocompromised patients, especially with hematological malignancy, transplantation, or diabetes mellitus. Rhino-orbito-cerebral and pulmonary mucormycosis are the predominant forms. Interestingly, location is associated with the underlying disease as pulmonary mucormycosis is more frequent in hematological malignancy patients whereas rhino-orbito-cerebral mucormycosis is associated with diabetes. Cutaneous mucormycosis results from direct inoculation, mainly after trauma or surgery. Gastro-intestinal mucormycosis occurs after ingestion of contaminated food or with contaminated device and involves the stomach or colon. Disseminated disease is the most severe form and is associated with profound immunosuppression. Uncommon presentations with endocarditis, osteoarticluar or isolated cerebral infections are also described. Finally, health-care associated mucormycosis is a matter of concern in premature newborns and burn units. Clinical symptoms and CT scan findings are not specific, only the early reversed halo sign is associated with pulmonary mucormycosis. Circulating Mucorales DNA detection is a recent promising diagnostic tool that may lead to improving the diagnosis and prompting therapeutic initiation that should include antifungal treatment, correction of the underlying disease and surgery when feasible. MDPI 2019-03-14 /pmc/articles/PMC6462957/ /pubmed/30875744 http://dx.doi.org/10.3390/jof5010023 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Serris, Alexandra Danion, François Lanternier, Fanny Disease Entities in Mucormycosis |
title | Disease Entities in Mucormycosis |
title_full | Disease Entities in Mucormycosis |
title_fullStr | Disease Entities in Mucormycosis |
title_full_unstemmed | Disease Entities in Mucormycosis |
title_short | Disease Entities in Mucormycosis |
title_sort | disease entities in mucormycosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462957/ https://www.ncbi.nlm.nih.gov/pubmed/30875744 http://dx.doi.org/10.3390/jof5010023 |
work_keys_str_mv | AT serrisalexandra diseaseentitiesinmucormycosis AT danionfrancois diseaseentitiesinmucormycosis AT lanternierfanny diseaseentitiesinmucormycosis |